Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 27, 1997

View Archived Issues

MMP inhibitors synthesized by Otsuka

Japanese researchers describe anticoagulants

Taisho discloses promoters of NGF production

Selectin inhibitors from TBC

Selective nAChR ligands prepared by Novo Nordisk

Cytotoxic colchicine derivatives from Indena

Pfizer's new antifungal agents

Harvard College discloses vascular injury-associated gene

ArQule reports financial results for fourth quarter and year ended December 31, 1996

Cephalon announces 1996 financial results

Enzon reports second-quarter results

The Liposome Company reports fourth-quarter and 1996 results

Vion Pharmaceuticals reports fourth-quarter and year-end financial results

Mediator release inhibitors described by French investigators

Candidate proton pump inhibitor described by Dainippon

GSH deficiency linked to impaired survival in HIV/AIDS

Positive clinical results for inhaled indomethacin

Cell Genesys expands trials of AIDS gene therapy

Glaxo Wellcome evaluates ondansetron alone and in combination for emesis

Medicis acquires topical steroids

Positive results reported for VasoCare in MI

Axcan H. pylori trial nearing completion

AEterna codevelopment agreement for AE-941

Optivax phase I results reported at AAAI/AAI/CIS meeting

PathoGenesis to seek approval for tobramycin

Italian researchers report effective combination therapy for HIV-associated NHL

IND filed for SunPharm IBD treatment

Riluzole now available in France

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...